Communicable disease and health protection quarterly review: April to June 2004

Journal of Public Health

Volumn 26, Issue 4, 2004, Pages 396-399

[No Author Info available]

Author keywords

Communicable disease; Emergency planning; Emerging infections; Healthcare associated infections

Indexed keywords

RABIES VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; COMMUNICABLE DISEASE; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROMOTION; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VIRUS A; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SURGICAL INFECTION; TRAVEL; UNITED KINGDOM; WEST NILE FLAVIVIRUS; ZOONOSIS;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISASTER PLANNING; DISEASE OUTBREAKS; GREAT BRITAIN; HUMANS; POPULATION SURVEILLANCE;

EID: 11244291115     PISSN: 17413842     EISSN: None     Source Type: Journal    
DOI: 10.1093/pubmed/fdh194     Document Type: Review

References (19)

1. Department of Health. CMO to step up fight against hospital infections. (press release) 2003/0222. London: Department of Health, Monday 9 June 2003. Available at 〈http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/ PressReleasesNotices/fs/en?CONTENT_ID=4047130&chk=6M5jVP〉.
2. Public Health Laboratory Service (PHLS). Activation of next phase of the healthcare associated infection. Commun Dis Rep CDR Wkly [serial online] 2003 [cited 30 Mar 2004]; 13: News. Available at 〈http://www.hpa.org.uk/cdr/ PDFfiles/2003/cdr2403.pdf〉.
3. HPA. Pyogenic and non-pyogenic streptococcal bacteraemias, England, Wales, and Northern Ireland: 2003. Commun Dis Rep Weekly [serial online] 2004 [cited16 April 2004]; 14: Bacteraemia. Available at 〈http://www.hpa.org.uk/ cdr/PDFfiles/2004/cdr1504.pdf〉.
4. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 [Suppl]: 3-12.
5. Schalen C. European surveillance of severe group A streptococcal disease. Eurosurveillance Weekly [serial online] 2002 [cited 15 April 2004]; 6: 020829. Available at 〈http://www.eurosurveillance.org/ew/ 2002/020829.asp〉.
6. PHLS. Enhanced surveillance of invasive group A streptococcal infections. Commun Dis Rep Weekly [serial online] 2002 [cited 15 April 2004]; 12: news. Available at 〈http://www.hpa.org.uk/cdr/PDFfiles/2002/cdr5102.pdf〉.
7. Medicines and Healthcare Products Regulatory Agency. Flexible and rigid endoscopes. Medical Device Alert MDA/2004/028. London: MHRA, 23 June 2004. Available at 〈http://www.mhra.gov.uk/〉.
8. British Society for Gastroenterology. Clinical practice. Guidelines [online] [cited 24 June 2004]. London: British Society for Gastroenterology, 2004. Available at 〈http://www.bsg.org.uk/clinical_prac/guidelines. htm〉.
9. Medicines and Health Care Products Regulatory Agency. Class 1 drug alert (immediate action): A ventis Pasteur MSD. Rabies Vaccine BP (Rab/Vac), PL 6745/0053. London: MHRA, 5 April 2004. Available at 〈http://medicines.mhra. gov.uk/ourwork/monitorsafequalmed/defmedsrepcen/rabvac_5404.pdf〉.
10. SARS: one suspected case reported in China. Communicable Disease Surveillance and Response. [online] [cited 14 September 2004]. Geneva: World Health Organization, 2004. Available at 〈http://www.who.int/csr/don/ 2004_04_22/en/〉.
11. China confirms SARS infection in another previously reported case; summary of cases to date - Update 5. Communicable Disease Surveillance and Response. [online] [cited 14 September 2004]. Geneva: World Health Organization, 2004. Available at 〈http://www.who.int/csr/don/2004_04_30/en/〉.
12. Investigation into China's recent SARS outbreak yields important lessons for global public health [online] [cited 14 September 2004]. World Health Organization Western Pacific Region, 2004. Available at 〈http://www.wpro. who.int/sars/docs/update/update_07022004.asp〉.
13. Centers for Disease Control and Prevention. Brief Report: Vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 322-3. Available at 〈http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5315a6.htm〉.
14. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565-567. Available at 〈http:// www.cdc.gov/mmwr//preview/mmwrhtml/ mm5126a1.htm〉.
15. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-1347.
16. Centers for Disease Control and Prevention. Public health dispatch: vancomycin-resistant Staphylococcus aureus. Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 902. Available at 〈http://www.cdc.gov/mmwr//preview/ mmwrhtml/mm5126a1.htm〉.
17. Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 2004; 38: 1049-1055.
18. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48: 275-280.
19. Department of Health. Winning Ways. Working together to reduce healthcare associated infection in England. London, Department of Health, 2003.